Thursday, September 28th

Program Schedule

Click on session titles for details
Start End Session Location
08:30 10:00 Saga Hall
Moderators: Jeanette Boudreau, Dalhousie University
Fredrik Berg Thorén, University of Gothenburg
08:30
Thierry Walzer, Inserm, Lyon
Uncoupling of functional paralysis and T-cell like transcriptional exhaustion program in NK cells responding to lymphoma
08:50
Cristhiane Favero De Aguiar, Trinity College Dublin
Metabolic and functional diversity of tumor-infiltrating NK cells
09:10
Jeanette Boudreau, Dalhousie University
Schroëdinger’s NK cells and immune cell co-ordination in the solid tumor microenvironment
09:30
Joey Li, University of California Los Angeles
MEF2C is a critical regulator of human NK cell metabolism
09:40
Sam Sheppard , Imperial College London
Fatty acid metabolism promotes natural killer cell cytotoxicity and anti-tumor function
09:50
Katja Srpan, Memorial Sloan Kettering Cancer Center
PD-L1 ligation enhances NK cell cytotoxicity by inducing metabolic shift
10:00 10:30 Coffee Break Foyer
10:30 12:00 Saga Hall
Moderators: Ashley Moffett, University of Cambridge
Nicole Marquardt, Karolinska Institutet
10:40
Jenny Mjösberg, Karolinska Institutet
Local differentiation of human ILCs in the inflamed and tumorous colon
11:00
Francesco Colucci, University of Cambridge
Tissue Education of Uterine NK cells
11:20
Niklas Björkström, Karolinska Institutet
Tissue-residency, recirculation, and diversity patterns of human natural killer cells
11:40
Marco Colonna, Washington University School of Medicine
Development and Diversity of ILC1
12:00 13:30 Lunch Restaurant
12:15 13:00 Saga Hall
Dr. Hannah Isles, Associate Editor Science Immunology
13:30 14:30 Saga Hall
Moderators: Aura Muntasell, Hospital del Mar Medical Research Institute
Sytse Piersma, Washington University in St Louis
13:30
Katherine Hsu, Memorial Sloan Kettering Cancer Center
Title to be announced
13:50
Bethany Mundy-Bosse, The Ohio State University
Epigenetic Dysregulation of NK Cell Development in Myeloid Malignancies
14:10
Frank Cichocki, University of Minnesota
BCL11B: A Transcription Factor That Sculpts Hematopoietic and NK Cell Populations
14:30 15:30 Saga Hall
Moderators: Salim Khakoo, University of Southampton
Victoria Male, Imperial College London
14:30
Hui Peng, University of Science and Technology of China
Development and function of liver-resident NK cells/ILC1s: from fetal to adult life
14:40
Inga Elisabeth Rødahl, Karolinska Institutet
Tracking tissue-dependent gene expression in fetal NK cells at the clonal level
14:50
Aline Pfefferle, Karolinska Institutet
A Temporal Transcriptional Reference Map of Human Natural Killer Cells
15:00
Samantha Barnes, University of Western Australia
Transcriptional profiling of highly functional natural killer cells reveals novel drivers of anti-cancer immunity
15:10
John Roy Lozada, University of Minnesota
A Single-Cell Transcriptomic Atlas of Natural Killer (NK) Cells Across Solid Tumors: A Roadmap for Enhancing NK Cell Immunotherapies
15:20
Clara Serger , University Hospital Basel
Characterization of the chromatin and transcriptional landscapes of intratumoral NK cells using single cell multiomics
15:30 16:00 Coffee Break Foyer
16:00 17:50 Saga Hall
Moderators: Fernando Guimaraes, The University Of Queensland
Melissa Berrien-Elliott, Washington University School of Medicine
16:00
David Raulet, University Of California Berkeley
Increasing the efficacy of NK cells in cancer immunotherapy
16:20
Satu Mustjoki, University of Helsinki
Functional profiling of NK cell cytotoxicity in hematological cancers
16:40
Amir Horowitz, Mount Sinai
Tumor HLA-E expression and CMV infection modulate NK cell activity in human bladder cancer
17:00
Adelheid Cerwenka, Heidelberg University, Medical Faculty Mannheim
Title to be announced
17:20
Hanna Duan , University of Helsinki
Acute myeloid leukemia patients trigger distinct activation patterns in expanded NK cells upon treatment
17:30
Jake Myers, University of Minnesota
Exhaustion induces transcriptional and epigenetic alterations in human NK cells that weaken NK cell activation through reduced ERK1/2 signaling and cell migration
17:40
Dagmar Gotthardt, University of Veterinary Medicine Vienna
NK cell senescence as barrier to malignant transformation
20:00 00:00 Gala Dinner Saga Hall

Gold Sponsors

Vycellix Logo
Fate Logo
Sanofi Logo

Silver Sponsors

ScaleReady Logo
MaxCyte Logo

Bronze Sponsors

Zelluna Logo
XNK Logo
Miltenyi Logo
Innate Pharma logo
Oncopeptides Logo
Affimed Logo
ImmuneBridge Logo
CellGenix Logo
Cellmover Logo

Academic Partners

SJI Logo
NextGenNK Logo
Prima Logo
UiO Logo
OUS Logo